Direct Answer

Eli Lilly reports revenue across 3 product and service lines in its fiscal 2025 Form 10-K. Product is the largest, with $61.0 billion of revenue (94% of the total), followed by Collaboration and Other Revenue at $4.2 billion (6%).

How Does Eli Lilly Make Money?

Product supplies 94% of revenue, so Eli Lilly's results move mostly with that one business; the others matter more for diversification than for the headline number. Between fiscal 2024 and 2025, Product grew fastest (+49.6%) and Collaboration and Other Revenue slowest (-1.7%), so the revenue mix tilts toward Product while that gap lasts.

Product or serviceFY2025 revenueFY2024 revenueShare of revenueChange
Product$61.0 billion$40.7 billion93.5%49.6%
Collaboration and Other Revenue$4.2 billion$4.3 billion6.5%-1.7%
Jardiance$3.4 billion$3.3 billion5.3%2.7%
Bar chart of Eli Lilly revenue by product line for fiscal 2025: Product 93.5%, Collaboration and Other Revenue 6.5%, Jardiance 5.3%.
Eli Lilly revenue by product line as a share of total revenue, from the table above. The largest is highlighted. Select the chart to open it full size.

What the Segment Figures Do Not Show

The rows above add up to 105% of Eli Lilly's reported revenue for fiscal 2025; the difference is intersegment eliminations, corporate revenue or items the company reports outside its segments. Segment definitions are management's choice and change when a company reorganizes, in which case it restates prior years in the next filing, so a multi-year comparison should use the figures from a single filing. Revenue shows where sales come from, not where profit or cash is earned: a small segment can carry most of the margin.

Where These Numbers Come From

Every figure on this page is a value Eli Lilly reported in the segment note and revenue disclosures of its Form 10-K filed February 12, 2026 (accession 0000059478-26-000013), read from the SEC's Financial Statement Data Sets. The prior-year column is the comparative figure from that same filing, so it reflects any restatement for a change in segments. Category names are the company's own XBRL labels, lightly reformatted for reading.

Rows that only total other rows (for example a "Products" line beside the individual products) are left out so nothing is counted twice. This page is educational and describes reported history for fiscal 2025; it is not a forecast or a recommendation.

Frequently Asked Questions

What are Eli Lilly's main products and services?

In its fiscal 2025 Form 10-K, Eli Lilly reports revenue for Product, Collaboration and Other Revenue and Jardiance.

Which part of Eli Lilly brings in the most revenue?

Product, with $61.0 billion of revenue in fiscal 2025, or 94% of the total.

Where does Eli Lilly report its segment results?

In the segment note to the financial statements in its Form 10-K, most recently filed February 12, 2026, alongside management's discussion of each segment's results.

References

Related Pages